Topic hub
How clinicians use AI in practice
Where doctors already lean on AI, where they refuse to, and what would change that.
What did the panels say about how clinicians use ai in practice?
- #
55.1%
55.1% (109 of 198) would rely on an AI-generated one-page summary of a newly approved medicine's pivotal trial, a 5 or more of 7, when every number links to the exact line of the published paper it comes from, against 0 of 198 when it shows no sources and 72.7% (144 of 198) when a named independent physician has also checked it against the paper. — AI summaries of a new drug's trial: 0 of 198 US physicians and other prescribers would rely on one with no sources, 55.1% when every number links to the paper and 72.7% once a named physician has checked it
base 198
- #
2
Almost nobody objects to AI writing the content. They object to nobody checking it. — Only 2 of 173 US physicians discount pharmaceutical promotion because AI wrote it, while 63% discount content no expert has reviewed
base 173
- #
96.3%
96.3% of US healthcare professionals are likely to recommend an FDA-cleared app alongside a long-term medicine when insurance covers it and the patient pays $0; when it is not covered and the patient pays $30 a month none are likely to, and at $100 all 81 are very unlikely to — Clinicians will recommend a health app alongside a medicine only when it costs the patient nothing: 96.3% would if it is covered, none at $30 a month
base 81
What has Brox published on how clinicians use ai in practice?Newest first
-
AI summaries of a new drug's trial: 0 of 198 US physicians and other prescribers would rely on one with no sources, 55.1% when every number links to the paper and 72.7% once a named physician has checked it
55.1% 55.1% (109 of 198) would rely on an AI-generated one-page summary of a newly approved medicine's pivotal trial, a 5 or more of 7, when every number links to the exact line of the published paper it comes from, against 0 of 198 when it shows no sources and 72.7% (144 of 198) when a named independent physician has also checked it against the paper. (base 198)
Read -
Only 2 of 173 US physicians discount pharmaceutical promotion because AI wrote it, while 63% discount content no expert has reviewed
2 Almost nobody objects to AI writing the content. They object to nobody checking it. (base 173)
Read -
Clinicians will recommend a health app alongside a medicine only when it costs the patient nothing: 96.3% would if it is covered, none at $30 a month
96.3% 96.3% of US healthcare professionals are likely to recommend an FDA-cleared app alongside a long-term medicine when insurance covers it and the patient pays $0; when it is not covered and the patient pays $30 a month none are likely to, and at $100 all 81 are very unlikely to (base 81)
Read
What do people ask about how clinicians use ai in practice?
- Would a physician trust an AI summary of a new drug's trial data over the label or a rep?
- Over the rep but not the label: 55.1% of US physicians and other prescribers on the Brox panel would rely on an AI summary of a new medicine's pivotal trial when every number links to the published paper, none would rely on one with no sources, and 66.2% would ignore the sales rep first against 24.2% the AI summary and 0% the FDA label (n=198, November 2026).Read the insight
- What share of physicians discount pharmaceutical promotional content because AI was involved in writing it?
- Only 2 of 173 US physicians on the Brox panel would discount pharmaceutical promotional content because AI was involved in writing it, while 63% say they begin discounting it when no expert has reviewed it (n=173, October 2026).Read the insight
- What would make a clinician recommend a digital therapeutic or app alongside a medicine?
- In October 2026, 96.3% of US healthcare professionals on the Brox panel (n=81) were likely to recommend an FDA-cleared app alongside a long-term medicine when insurance covered it and the patient paid $0, but none were likely to when the patient paid $30 a month.Read the insight
Other topics
How should you read these findings?
Where the numbers come from. Every figure on this site is a predicted response from Brox clones: behavioural replicas of real people, each built from a long-form interview with that person. The base under each figure is the number of clones behind it.
Where the real data comes from. The long-form video interviews with the real people the clones are built from. A quote is always shown with the interview line it was predicted from.
What you can take away. Insights publish their tabulation as CSV and JSON: question, option, count, percentage and base. Never per-person rows.
Ask this of your own customers: humans@brox.ai